We’re delighted to reveal that Morningside Pharmaceuticals has achieved full HM Revenue & Customs Authorised Economic Operator (AEO F) status.
Speaking about the achievement, our Chairman, Dr Nik Kotecha OBE, said: “Congratulations and well done to the Morningside Team for achieving the AEO Customs (C) and Security (S) accreditations.
“This is a great achievement which involved submitting an application to HMRC, followed by an audit and inspection of our premises and supply chain processes. This accreditation is important for both importing and exporting businesses like Morningside because it is an international standard that is recognised by not just the EU, but countries all over the world, and shows that our supply chain processes are robust.
“It also ensures that the holder may be able to benefit from arrangements under Mutual Recognition Agreements (MRA), which are agreed with third country customs authorities. Businesses looking to trade with these new markets will enjoy faster clearance at the borders, less interventions and lower risk scores.
“This accreditation will be very beneficial to UK businesses, as we near the end of the Transition Period, and look to establish new trade routes with countries within and outside of the EU.”